Literature DB >> 33546719

Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats.

Stephanie Mohammed1, Venkatesan Sundaram2, Nikolay Zyuzikov3.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common complex endocrine disorder affecting approximately 2-20% of reproductive aged females. Tumour Treating Fields (100-300 kHz) is a recent innovative, non-invasive therapeutic approach to cancer therapy. This frequency as an alternative therapy for the management of polycystic ovaries has not yet been explored.
OBJECTIVES: To explore the effect of full-body exposure of 150 kHz Electromagnetic Radiation (EMR), on the development of polycystic ovaries in an estradiol valerate-induced PCO rat model.
METHOD: Twenty-one female adult rats were divided into three groups (n = 7 each): control, Estradiol Valerate (EV) and EV + EMR groups. The EV + EMR group was subjected to full body exposure at 150 kHz EMR continuously for eight consecutive weeks. Estradiol valerate was administered orally to induce polycystic ovaries in EV and EV + EMR groups. Body and ovarian weights were recorded and analysed. The regularity of the estrous cycle was assessed in all three groups. The histological study of ovarian tissue was carried out by haematoxylin and eosin staining. The serum concentration levels of Luteinizing Hormone (LH), Follicle-Stimulating Hormone (FSH) and testosterone were measured using the ELISA method.
RESULTS: The body and ovary weights did not differ significantly between the EV and EV + EMR groups. The estrous cycle was found to be irregular in both the EV and EV + EMR groups. Ovarian histology revealed near normal morphology with little or no degenerative and morphological changes in developing follicles in the exposed group. Histometrical analysis showed an increased number of developing follicles and a significant reduction in the number and size of follicular cysts (p < 0.05) in the EV + EMR group. Hormonal analysis revealed no significant difference in the testosterone and FSH levels between the EV + EMR and EV groups. However, the LH, LH/FSH ratio decreased significantly in the EV + EMR group compares to the EV group.
CONCLUSION: The 150 kHz EMR appear to have little or no degenerative and morphological changes in the developing follicles, an increased number of typical developing follicles and a significant reduction in the number and size of the follicular cysts (p < 0.05).

Entities:  

Keywords:  150 kHz electromagnetic radiation; Estradiol Valerate; Polycystic ovary model

Year:  2021        PMID: 33546719      PMCID: PMC7866699          DOI: 10.1186/s13048-021-00774-4

Source DB:  PubMed          Journal:  J Ovarian Res        ISSN: 1757-2215            Impact factor:   4.234


  26 in total

Review 1.  Oocyte Competence in Women with Polycystic Ovary Syndrome.

Authors:  Stefano Palomba; Jessica Daolio; Giovanni Battista La Sala
Journal:  Trends Endocrinol Metab       Date:  2016-12-14       Impact factor: 12.015

2.  Neurotransmitter alteration in a testosterone propionate-induced polycystic ovarian syndrome rat model.

Authors:  Nirja K Chaudhari; Laxmipriya P Nampoothiri
Journal:  Horm Mol Biol Clin Investig       Date:  2017-02-01

3.  Polycystic ovarian condition in estradiol valerate-treated rats: spontaneous changes in characteristic endocrine features.

Authors:  A Schulster; R Farookhi; J R Brawer
Journal:  Biol Reprod       Date:  1984-10       Impact factor: 4.285

4.  The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome.

Authors:  Nadira S Kakoly; Arul Earnest; Helena J Teede; Lisa J Moran; Anju E Joham
Journal:  Diabetes Care       Date:  2019-01-31       Impact factor: 19.112

5.  Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease.

Authors:  Hasan Kafali; Mehmet Iriadam; Ilyas Ozardali; Nurettin Demir
Journal:  Arch Med Res       Date:  2004 Mar-Apr       Impact factor: 2.235

Review 6.  Neuroendocrine involvement in aging: evidence from studies of reproductive aging and caloric restriction.

Authors:  J F Nelson; K Karelus; M D Bergman; L S Felicio
Journal:  Neurobiol Aging       Date:  1995 Sep-Oct       Impact factor: 4.673

7.  Preservation of mouse ovarian tissue follicle morphology and ultra-structure after vitrifying in biotechnological protocols.

Authors:  Hamid Tayefi Nasrabadi; Maryam Gavami; Abolfazl Akbarzadeh; Rahim Beheshti; Daryosh Mohammadnejad; Ali Abedelahi
Journal:  J Ovarian Res       Date:  2015-03-06       Impact factor: 4.234

8.  The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis.

Authors:  Tao Ding; Paul J Hardiman; Irene Petersen; Fang-Fang Wang; Fan Qu; Gianluca Baio
Journal:  Oncotarget       Date:  2017-07-12

9.  Tumor Treating Fields for Glioblastoma Treatment: Patient Satisfaction and Compliance With the Second-Generation Optune® System.

Authors:  Adrian Kinzel; Michael Ambrogi; Michael Varshaver; Eilon D Kirson
Journal:  Clin Med Insights Oncol       Date:  2019-01-29

10.  Effect of non-ionizing electromagnetic field on the alteration of ovarian follicles in rats.

Authors:  Seyed Shahin Ahmadi; Amir Afshin Khaki; Nava Ainehchi; Alireza Alihemmati; Azam Asghari Khatooni; Arash Khaki; Ali Asghari
Journal:  Electron Physician       Date:  2016-03-25
View more
  1 in total

1.  Polycystic ovary rat model exposure to 150 kHz intermediate frequency: hypothalamic-pituitary-ovarian axis at the receptor, cellular, tissue, and hormone levels.

Authors:  Stephanie Mohammed; Venkatesan Sundaram; Chalapathi R Adidam Venkata; Nikolay Zyuzikov
Journal:  J Ovarian Res       Date:  2021-12-11       Impact factor: 4.234

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.